Autoimmune retinopathies which broadly overlap cancer associated retinopathy and non-paraneoplastic autoimmune retinopathy (npAIR) are complex diagnoses with visually devastating consequences 1.There is no consensus on systemic immunosuppression, though a recent meta-analysis of case reports has suggested benefit 2.We have seen limited response to classical immunosuppression in our practice and so have historically offered treatment with intravenous immunoglobulin (IVIg) which is commissioned in the UK, and here report on a cohort starting treatment over a 10-year period.Testing for anti-retinal antibodies (ARAb) was performed in all 18 patients but even in those that were negative (5/18), if a
Abraham et al. (Thu,) studied this question.